Preparing for Organic Growth and Resilience
The biopharma market is the fastest-growing pharmaceutical segment. Against this backdrop, we have been investing significantly in the expansion of our production capacities in all geographies – the Americas, Europe, and Asia. We are expanding our global presence with customers by setting up Customer Interaction Centers, and we are investing in a substantial expansion of our activities in South Korea.
In addition to preparing our production and research infrastructure for organic growth, we have also invested in resilience in the face of geopolitical uncertainties, with the goal of continuing to meet the highest standards for delivery reliability and product quality in all regions.